SCHEMBL19418772

SCHEMBL19418772

Brc1cncc(SCC2CCCCC2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.39
MAPT P10636 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
KDM6B O15054 1/20 0.38
KDM4A O75164 1/20 0.38
KDM4D Q6B0I6 1/20 0.38
KDM3B Q7LBC6 1/20 0.38
HIF1AN Q9NWT6 1/20 0.38
KDM2A Q9Y2K7 1/20 0.38
DAO P14920 1/20 0.38
ALDH1A1 P00352 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
LMNA P02545 3/20 0.35
NPC1 O15118 2/20 0.35
ALOX12 P18054 1/20 0.35
AR P10275 2/20 0.34
METAP2 P50579 1/20 0.34
TAS1R3 Q7RTX0 1/20 0.33
TAS1R1 Q7RTX1 1/20 0.33
TAS1R2 Q8TE23 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19420474 0.84 CHRNB2 (0.38) CHRNB2CHRNA4
SCHEMBL21372192 0.75 AR (0.40) KDM6BKDM4AKDM4DKDM3BHIF1AN
SCHEMBL13400234 0.75 CTSK (0.48) L3MBTL1MAPTTDP1ALDH1A1SMN1; SMN2
SCHEMBL1710383 0.75 CTSK (0.48) L3MBTL1MAPTTDP1ALDH1A1SMN1; SMN2
SCHEMBL19418737 0.75 KDM6B (0.42) L3MBTL1MAPTTDP1KDM6BKDM4A
SCHEMBL1710917 0.74 AR (0.37) L3MBTL1MAPTTDP1KDM6BKDM4A
SCHEMBL1722291 0.74 AR (0.37) L3MBTL1MAPTTDP1KDM6BKDM4A
SCHEMBL3386713 0.74 CYP1A2 (0.44) L3MBTL1MAPTTDP1ALDH1A1AR
SCHEMBL1710511 0.73 CTSK (0.49) L3MBTL1MAPTTDP1ALDH1A1AR
SCHEMBL1710793 0.72 MAPT (0.34) L3MBTL1MAPTTDP1KDM6BKDM4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170283397-A1 SUBSTITUTED 1-H-INDOL-3-YL-BENZAMIDE AND 1, 1'-BIPHENYL ANALOGS AS HISTONE DEMETHYLASE INHIBITORS UNIV UTAH RES FOUND (US) 2017-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170283397-A1 SUBSTITUTED 1-H-INDOL-3-YL-BENZAMIDE AND 1, 1'-BIPHENYL ANALOGS AS HISTONE DEMETHYLASE INHIBITORS KDM1A, KDM1B, KDM3A L3MBTL1 240/4885MAPT 1387/4885TDP1 263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.